Oncotelic issues $0.5M in convertible notes at $0.07/share to repay existing debt

Oncotelic Therapeutics, Inc.

Issued two convertible notes: $0.25M to Talos Victory Fund and $0.25M to Mast Hill Fund.
Notes carry 12% annual interest, mature in one year, convertible at $0.07 per share.
Proceeds used to fully repay May 2021 Geneva Note ($203,750) and June 2021 Geneva Note ($103,750).
Financing round aims for up to $1.0M; first two tranches total $0.5M.
JH Darbie & Co. entitled to 10% cash finder's fee and 10% warrant coverage.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.